• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    Prothena Corporation plc (PRTA)

    -NasdaqGS
    35.99 Down 1.55(4.13%) Apr 17, 4:00PM EDT
    |After Hours : 35.99 Down 0.00 (0.01%) Apr 17, 4:22PM EDT
    Add to Portfolio
    Prev Close:37.54
    Open:37.00
    Bid:N/A
    Ask:38.06 x 100
    1y Target Est:45.00
    Beta:0.5
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:35.84 - 37.43
    52wk Range:16.71 - 45.00
    Volume:440,314
    Avg Vol (3m):494,260
    Market Cap:986.09M
    P/E (ttm):N/A
    EPS (ttm):-0.29
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):20.23
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.66
    Quarterly EPS Est (Mar-15) :-0.59
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):0.10

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on the discovery, development, and commercialization of protein immunotherapy programs for the treatment of diseases that involve amyloid or cell adhesion in Ireland. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback